- Home
- DNTH vs ARRY Comparison
DNTH vs ARRY Comparison
Compare DNTH & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- ARRY
- Stock Information
- Founded
- DNTH 2015
- ARRY 1989
- Country
- DNTH United States
- ARRY United States
- Employees
- DNTH N/A
- ARRY N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- ARRY Semiconductors
- Sector
- DNTH Health Care
- ARRY Technology
- Exchange
- DNTH Nasdaq
- ARRY Nasdaq
- Market Cap
- DNTH 1.5B
- ARRY 1.3B
- IPO Year
- DNTH N/A
- ARRY 2020
- Fundamental
- Price
- DNTH $34.50
- ARRY $8.81
- Analyst Decision
- DNTH Strong Buy
- ARRY Buy
- Analyst Count
- DNTH 10
- ARRY 19
- Target Price
- DNTH $66.38
- ARRY $9.47
- AVG Volume (30 Days)
- DNTH 947.1K
- ARRY 7.1M
- Earning Date
- DNTH 11-06-2025
- ARRY 11-06-2025
- Dividend Yield
- DNTH N/A
- ARRY N/A
- EPS Growth
- DNTH N/A
- ARRY N/A
- EPS
- DNTH N/A
- ARRY N/A
- Revenue
- DNTH $4,854,000.00
- ARRY $1,171,244,000.00
- Revenue This Year
- DNTH N/A
- ARRY $34.85
- Revenue Next Year
- DNTH N/A
- ARRY $12.87
- P/E Ratio
- DNTH N/A
- ARRY N/A
- Revenue Growth
- DNTH 17.87
- ARRY 6.36
- 52 Week Low
- DNTH $13.37
- ARRY $3.76
- 52 Week High
- DNTH $40.16
- ARRY $9.99
- Technical
- Relative Strength Index (RSI)
- DNTH 50.57
- ARRY 56.89
- Support Level
- DNTH $33.96
- ARRY $8.00
- Resistance Level
- DNTH $40.16
- ARRY $9.67
- Average True Range (ATR)
- DNTH 2.12
- ARRY 0.65
- MACD
- DNTH -0.97
- ARRY 0.05
- Stochastic Oscillator
- DNTH 4.03
- ARRY 60.00
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.